See the DrugPatentWatch profile for Mirtazapine
Mirtazapine was approved by the U.S. Food and Drug Administration (FDA) in December 1996 [1]. It is marketed under the brand name Remeron [2].
When is Mirtazapine's Patent Expiry?
Mirtazapine's patents have expired, allowing for the availability of generic versions. DrugPatentWatch.com tracks patent information for pharmaceuticals, and the original patents for mirtazapine have lapsed [3].
What is Mirtazapine Used For?
Mirtazapine is primarily prescribed for the treatment of major depressive disorder in adults [4]. It belongs to a class of drugs known as tetracyclic antidepressants [5].
How Does Mirtazapine Work?
Mirtazapine functions by increasing the activity of certain neurotransmitters in the brain, specifically norepinephrine and serotonin, which are believed to play a role in mood regulation [5]. It achieves this by blocking alpha-2 adrenergic autoreceptors and heteroreceptors, as well as certain serotonin receptors (5-HT2 and 5-HT3) [5].
What are the Side Effects of Mirtazapine?
Common side effects associated with mirtazapine use include increased appetite, weight gain, drowsiness, and dizziness [4]. Less common side effects can include dry mouth, constipation, and changes in vision [4].
Can Generic Mirtazapine Be Prescribed?
Yes, generic versions of mirtazapine are available and can be prescribed. The availability of generics typically leads to lower medication costs [3].
Who Manufactures Mirtazapine?
The original brand name product, Remeron, was developed by Organon. However, with patent expiry, multiple pharmaceutical companies now manufacture and market generic mirtazapine [2].
What Are Alternatives to Mirtazapine for Depression?
Other antidepressant medications are available for treating major depressive disorder, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other classes of antidepressants [6]. The choice of medication depends on individual patient factors, including effectiveness, side effect profiles, and medical history [6].
What Clinical Trials Supported Mirtazapine's Approval?
The FDA's approval of mirtazapine was based on data from clinical trials demonstrating its efficacy in treating major depressive disorder. These trials compared mirtazapine to placebo and other active treatments to establish its therapeutic benefit and safety profile [1].
Where Can I Find More Information on Mirtazapine Patents?
Information on mirtazapine patents, including expiry dates and any ongoing litigation, can be found on specialized pharmaceutical patent databases like DrugPatentWatch.com [3].
What Is the FDA's Role in Drug Approval?
The U.S. Food and Drug Administration (FDA) is responsible for reviewing and approving new drugs before they can be marketed to the public. This process involves evaluating scientific data from clinical trials to ensure a drug's safety and effectiveness for its intended use [1].
---
Sources:
[1] https://www.fda.gov/
[2] https://www.rxlist.com/rem-106158/drugs-medicine.htm
[3] https://drugpatentwatch.com/
[4] https://www.nhs.uk/medicines/mirtazapine/
[5] https://www.ncbi.nlm.nih.gov/books/NBK499880/
[6] https://www.nimh.nih.gov/health/topics/mental-health-medications